Movement Alert｜Zai Lab Rises 5.75% in Regular Trading, Institutional Accumulation Filing Disclosed Amid Overnight US Rally

Market Focus06-18

On June 18, Zai Lab rose 5.75% in regular trading, trading at 14.34 HKD/share, with turnover of approximately 31.02 million HKD.

On the news front, the company recently disclosed a Schedule 13G/A filing revealing that institutional investors have increased their shareholdings, drawing market attention to continued capital inflows. Simultaneously, overnight US markets rallied broadly, with the Nasdaq surging 3.07% and the Dow Jones hitting a historical high. Chinese ADRs generally strengthened, boosting sentiment across the Hong Kong-listed biopharmaceutical sector.

Within the Biotechnology sector, Zai Lab significantly outperformed peers. Among sector constituents, BeiGene rose 0.89%, while Akeso fell 0.36%, Innovent Bio fell 0.6%, RemeGen fell 3.49%, and SKB Bio fell 1.19%.

Zai Lab is a biopharmaceutical holding company dedicated to addressing unmet medical needs in oncology, immunology, neuroscience, and infectious diseases through drug discovery, development, and commercialization. Its product portfolio includes Zejula, Optune, Qinglok, Nuvaira, and Vyvgart.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1199145208?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 09:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199145208","market":"us","top_or_hot":-1,"title":"Movement Alert｜Zai Lab Rises 5.75% in Regular Trading, Institutional Accumulation Filing Disclosed Amid Overnight US Rally","media":"Market Focus","content":"<p><p>On June 18, Zai Lab rose 5.75% in regular trading, trading at 14.34 HKD/share, with turnover of approximately 31.02 million HKD.</p><p>On the news front, the company recently disclosed a Schedule 13G/A filing revealing that institutional investors have increased their shareholdings, drawing market attention to continued capital inflows. Simultaneously, overnight US markets rallied broadly, with the Nasdaq surging 3.07% and the Dow Jones hitting a historical high. Chinese ADRs generally strengthened, boosting sentiment across the Hong Kong-listed biopharmaceutical sector.</p><p>Within the Biotechnology sector, Zai Lab significantly outperformed peers. Among sector constituents, BeiGene rose 0.89%, while Akeso fell 0.36%, Innovent Bio fell 0.6%, RemeGen fell 3.49%, and SKB Bio fell 1.19%.</p><p>Zai Lab is a biopharmaceutical holding company dedicated to addressing unmet medical needs in oncology, immunology, neuroscience, and infectious diseases through drug discovery, development, and commercialization. Its product portfolio includes Zejula, Optune, Qinglok, Nuvaira, and Vyvgart.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Zai Lab Rises 5.75% in Regular Trading, Institutional Accumulation Filing Disclosed Amid Overnight US Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Zai Lab Rises 5.75% in Regular Trading, Institutional Accumulation Filing Disclosed Amid Overnight US Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-18 09:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 18, Zai Lab rose 5.75% in regular trading, trading at 14.34 HKD/share, with turnover of approximately 31.02 million HKD.</p><p>On the news front, the company recently disclosed a Schedule 13G/A filing revealing that institutional investors have increased their shareholdings, drawing market attention to continued capital inflows. Simultaneously, overnight US markets rallied broadly, with the Nasdaq surging 3.07% and the Dow Jones hitting a historical high. Chinese ADRs generally strengthened, boosting sentiment across the Hong Kong-listed biopharmaceutical sector.</p><p>Within the Biotechnology sector, Zai Lab significantly outperformed peers. Among sector constituents, BeiGene rose 0.89%, while Akeso fell 0.36%, Innovent Bio fell 0.6%, RemeGen fell 3.49%, and SKB Bio fell 1.19%.</p><p>Zai Lab is a biopharmaceutical holding company dedicated to addressing unmet medical needs in oncology, immunology, neuroscience, and infectious diseases through drug discovery, development, and commercialization. Its product portfolio includes Zejula, Optune, Qinglok, Nuvaira, and Vyvgart.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09688","symbol_name":"再鼎医药","start_time":0,"source_url":"","article_id":"1199145208","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199145208","pubTimestamp":1781747000,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 18, Zai Lab rose 5.75% in regular trading, trading at 14.34 HKD/share, with turnover of approximately 31.02 million HKD.On the news front, the company recently disclosed a Schedule 13G/A...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09688":"再鼎医药"},"translate_title":"动向提示|再鼎医药常规交易涨5.75%隔夜美股涨势中披露机构增持备案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1},"content_text":"On June 18, Zai Lab rose 5.75% in regular trading, trading at 14.34 HKD/share, with turnover of approximately 31.02 million HKD.On the news front, the company recently disclosed a Schedule 13G/A filing revealing that institutional investors have increased their shareholdings, drawing market attention to continued capital inflows. Simultaneously, overnight US markets rallied broadly, with the Nasdaq surging 3.07% and the Dow Jones hitting a historical high. Chinese ADRs generally strengthened, boosting sentiment across the Hong Kong-listed biopharmaceutical sector.Within the Biotechnology sector, Zai Lab significantly outperformed peers. Among sector constituents, BeiGene rose 0.89%, while Akeso fell 0.36%, Innovent Bio fell 0.6%, RemeGen fell 3.49%, and SKB Bio fell 1.19%.Zai Lab is a biopharmaceutical holding company dedicated to addressing unmet medical needs in oncology, immunology, neuroscience, and infectious diseases through drug discovery, development, and commercialization. Its product portfolio includes Zejula, Optune, Qinglok, Nuvaira, and Vyvgart.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1199145208","isCrawlerRequest":true}